SMAD3 and osteoarthritis: The expression of SMAD3 decreases in patients with osteoarthritis owing to the inhibitory action of microRNA-16, thereby inhibiting the cell proliferation, increasing the expression of ADAMTS and metalloproteinase enzymes, and decreasing the expression of various components of the cellular matrix, such as collagen type II and Agricane.